ARKEMA (AKE.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:AKE - FR0010313833 - Common Stock
51.45 EUR
0 (0%)
Overall AKE gets a fundamental rating of 4 out of 10. We evaluated AKE against 74 industry peers in the Chemicals industry. AKE has an average financial health and profitability rating. AKE has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
AKE had positive earnings in the past year.
In the past year AKE had a positive cash flow from operations.
In the past 5 years AKE has always been profitable.
Each year in the past 5 years AKE had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 1.51%, AKE perfoms like the industry average, outperforming 55.41% of the companies in the same industry.
AKE has a Return On Equity (2.90%) which is in line with its industry peers.
AKE has a Return On Invested Capital (3.44%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for AKE is in line with the industry average of 6.48%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROIC | 3.44% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
1.3 Margins
The Profit Margin of AKE (2.22%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of AKE has declined.
The Operating Margin of AKE (6.35%) is better than 60.81% of its industry peers.
AKE's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 19.02%, AKE is doing worse than 70.27% of the companies in the same industry.
AKE's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% |
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
2. Health
2.1 Basic Checks
AKE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, AKE has more shares outstanding
The number of shares outstanding for AKE has been reduced compared to 5 years ago.
Compared to 1 year ago, AKE has a worse debt to assets ratio.
2.2 Solvency
AKE has an Altman-Z score of 1.86. This is not the best score and indicates that AKE is in the grey zone with still only limited risk for bankruptcy at the moment.
AKE's Altman-Z score of 1.86 is on the low side compared to the rest of the industry. AKE is outperformed by 66.22% of its industry peers.
The Debt to FCF ratio of AKE is 16.70, which is on the high side as it means it would take AKE, 16.70 years of fcf income to pay off all of its debts.
AKE has a Debt to FCF ratio (16.70) which is in line with its industry peers.
A Debt/Equity ratio of 0.50 indicates that AKE is somewhat dependend on debt financing.
AKE has a Debt to Equity ratio (0.50) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Altman-Z | 1.86 |
ROIC/WACC0.73
WACC4.71%
2.3 Liquidity
AKE has a Current Ratio of 2.73. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.73, AKE belongs to the top of the industry, outperforming 81.08% of the companies in the same industry.
AKE has a Quick Ratio of 1.92. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
AKE has a Quick ratio of 1.92. This is amongst the best in the industry. AKE outperforms 83.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 |
3. Growth
3.1 Past
The earnings per share for AKE have decreased strongly by -38.40% in the last year.
AKE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.10% yearly.
AKE shows a small growth in Revenue. In the last year, the Revenue has grown by 0.32%.
The Revenue has been growing slightly by 1.78% on average over the past years.
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%
3.2 Future
Based on estimates for the next years, AKE will show a decrease in Earnings Per Share. The EPS will decrease by -2.13% on average per year.
Based on estimates for the next years, AKE will show a small growth in Revenue. The Revenue will grow by 1.37% on average per year.
EPS Next Y-35.91%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPS Next 5Y-2.13%
Revenue Next Year-4.84%
Revenue Next 2Y-1.36%
Revenue Next 3Y0.39%
Revenue Next 5Y1.37%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.99, the valuation of AKE can be described as very reasonable.
Based on the Price/Earnings ratio, AKE is valued cheaper than 90.54% of the companies in the same industry.
When comparing the Price/Earnings ratio of AKE to the average of the S&P500 Index (25.65), we can say AKE is valued rather cheaply.
A Price/Forward Earnings ratio of 8.42 indicates a reasonable valuation of AKE.
Based on the Price/Forward Earnings ratio, AKE is valued cheaply inside the industry as 93.24% of the companies are valued more expensively.
AKE is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.45, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.99 | ||
| Fwd PE | 8.42 |
4.2 Price Multiples
94.59% of the companies in the same industry are more expensive than AKE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AKE is valued a bit cheaper than the industry average as 79.73% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.24 | ||
| EV/EBITDA | 4.44 |
4.3 Compensation for Growth
A cheap valuation may be justified as AKE's earnings are expected to decrease with -4.81% in the coming years.
PEG (NY)N/A
PEG (5Y)102.23
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
5. Dividend
5.1 Amount
AKE has a Yearly Dividend Yield of 7.23%, which is a nice return.
Compared to an average industry Dividend Yield of 3.18, AKE pays a better dividend. On top of this AKE pays more dividend than 94.59% of the companies listed in the same industry.
AKE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.23% |
5.2 History
On average, the dividend of AKE grows each year by 6.86%, which is quite nice.
Dividend Growth(5Y)6.86%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
129.52% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
AKE's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP129.52%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPA:AKE (11/25/2025, 9:11:54 AM)
51.45
0 (0%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners59.49%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap3.91B
Revenue(TTM)9.54B
Net Income(TTM)210.00M
Analysts73.33
Price Target65.98 (28.24%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.23% |
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP129.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.64%
Min EPS beat(2)-8.67%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-18.44%
Max EPS beat(4)-1.73%
EPS beat(8)3
Avg EPS beat(8)-4.83%
EPS beat(12)7
Avg EPS beat(12)1.09%
EPS beat(16)11
Avg EPS beat(16)10.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)-15.03%
PT rev (3m)-17.07%
EPS NQ rev (1m)-4.68%
EPS NQ rev (3m)-28.26%
EPS NY rev (1m)-7.1%
EPS NY rev (3m)-34.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.07%
Revenue NY rev (1m)-1.12%
Revenue NY rev (3m)-2.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.99 | ||
| Fwd PE | 8.42 | ||
| P/S | 0.41 | ||
| P/FCF | 17.24 | ||
| P/OCF | 3.85 | ||
| P/B | 0.54 | ||
| P/tB | 1.83 | ||
| EV/EBITDA | 4.44 |
EPS(TTM)5.15
EY10.01%
EPS(NY)6.11
Fwd EY11.87%
FCF(TTM)2.98
FCFY5.8%
OCF(TTM)13.36
OCFY25.96%
SpS124.15
BVpS95.11
TBVpS28.16
PEG (NY)N/A
PEG (5Y)102.23
Graham Number104.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROCE | 4.88% | ||
| ROIC | 3.44% | ||
| ROICexc | 3.86% | ||
| ROICexgc | 7.22% | ||
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% | ||
| FCFM | 2.4% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexgc growth 3Y-19.33%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Debt/EBITDA | 2.56 | ||
| Cap/Depr | 95.75% | ||
| Cap/Sales | 8.36% | ||
| Interest Coverage | 17.14 | ||
| Cash Conversion | 71.35% | ||
| Profit Quality | 108.1% | ||
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 1.86 |
F-Score5
WACC4.71%
ROIC/WACC0.73
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
EPS Next Y-35.91%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPS Next 5Y-2.13%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%
Revenue Next Year-4.84%
Revenue Next 2Y-1.36%
Revenue Next 3Y0.39%
Revenue Next 5Y1.37%
EBIT growth 1Y-21.16%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year49.9%
EBIT Next 3Y20.73%
EBIT Next 5Y12.34%
FCF growth 1Y-64.53%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-26.48%
OCF growth 3Y7%
OCF growth 5Y-2.92%
ARKEMA / AKE.PA FAQ
What is the ChartMill fundamental rating of ARKEMA (AKE.PA) stock?
ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.
What is the valuation status of ARKEMA (AKE.PA) stock?
ChartMill assigns a valuation rating of 6 / 10 to ARKEMA (AKE.PA). This can be considered as Fairly Valued.
How profitable is ARKEMA (AKE.PA) stock?
ARKEMA (AKE.PA) has a profitability rating of 4 / 10.
What are the PE and PB ratios of ARKEMA (AKE.PA) stock?
The Price/Earnings (PE) ratio for ARKEMA (AKE.PA) is 9.99 and the Price/Book (PB) ratio is 0.54.
How financially healthy is ARKEMA?
The financial health rating of ARKEMA (AKE.PA) is 5 / 10.